11 results  1 of 1 

1 Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity
Maurizio Benucci, Valentina Grossi, Mariangela Manfredi, Arianna Damiani, Maria Infantino, Paolo Moscato, Luigi Cinquanta, Elisa Gremese, Barbara Tolusso, Luca Petricca, Anna Laura Fedele, Stefano Alivernini, Fabiola Atzeni, Giovanni Minisola, Roberto Verna
Ann Lab Med.2020;40(2):101-113.   Published online 2019 October 23     DOI: http://dx.doi.org/10.3343/alm.2020.40.2.101
      
2 Influence of anti-tumor necrosis factor-alpha therapy to pregnant inflammatory bowel disease women and their children’s immunity
Ko Eun Lee, Sung-Ae Jung, Sang Hyoung Park, Chang Mo Moon, So Yeon Shim, Eun Soo Kim, Su Jin Cho, Seong-Eun Kim, Kwang Bum Cho, Suk-Kyun Yang
Intest Res.2019;17(2):237-243.   Published online 2019 February 8     DOI: http://dx.doi.org/10.5217/ir.2018.00071
      
3 Clinical Aspects and Treatments for Pediatric Inflammatory Bowel Diseases
Jin Soo Moon
Pediatr Gastroenterol Hepatol Nutr.2019;22(1):50-56.   Published online 2019 January 10     DOI: http://dx.doi.org/10.5223/pghn.2019.22.1.50
      
4 Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management
Dong Il Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin-Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasuo Suzuki, Kentaro Sugano, Mamoru Watanabe, Toshifumi Hibi, Amarender S. Puri, Suk-Kyun Yang
Intest Res.2018;16(1):17-25.   Published online 2018 January 18     DOI: http://dx.doi.org/10.5217/ir.2018.16.1.17
      
5 Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment
Dong Il Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin-Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasuo Suzuki, Kentaro Sugano, Mamoru Watanabe, Toshifumi Hibi, Amarender S. Puri, Suk-Kyun Yang
Intest Res.2018;16(1):4-16.   Published online 2018 January 18     DOI: http://dx.doi.org/10.5217/ir.2018.16.1.4
      
6 Efficacy of restarting anti-tumor necrosis factor α agents after surgery in patients with Crohn's disease
Sakiko Hiraoka, Shiho Takashima, Yoshitaka Kondo, Toshihiro Inokuchi, Yuusaku Sugihara, Masahiro Takahara, Seiji Kawano, Keita Harada, Jun Kato, Hiroyuki Okada
Intest Res.2018;16(1):75-82.   Published online 2018 January 18     DOI: http://dx.doi.org/10.5217/ir.2018.16.1.75
      
7 Comparing Effectiveness Rituximab (MabtheraⓇ) to Other Second-line Biologics for Rheumatoid Arthritis Treatment in Patients Refractory to or Intolerant of First-line Anti-tumor Necrosis Factor Agent: An Observational Study
Yong-Wook Park, Ki-Jo Kim, Hyung-In Yang, Bo Young Yoon, Sang Hyon Kim, Seong-Ho Kim, Jinseok Kim, Ji Seon Oh, Wan-Uk Kim, Yeon-Ah Lee, Jung-Yoon Choe, Min-Chan Park, Sang-Heon Lee
J Rheum Dis.2017;24(4):227-235.   Published online 2017 October 31     DOI: http://dx.doi.org/10.4078/jrd.2017.24.4.227
   
8 Fatal infections in older patients with inflammatory bowel disease on anti-tumor necrosis factor therapy
Way-Seah Lee, Najib Azmi, Ruey-Terng Ng, Sik-Yong Ong, Sasheela Sri La Ponnampalavanar, Sanjiv Mahadeva, Ida Hilmi
Intest Res.2017;15(4):524-528.   Published online 2017 October 23     DOI: http://dx.doi.org/10.5217/ir.2017.15.4.524
      
9 Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease
Kai-Chun Wu, Zhi Hua Ran, Xiang Gao, Minhu Chen, Jie Zhong, Jian-Qiu Sheng, Michael A Kamm, Simon Travis, Kori Wallace, Nael M Mostafa, Marisa Shapiro, Yao Li, Roopal B Thakkar, Anne M Robinson
Intest Res.2016;14(2):152-163.   Published online 2016 April 27     DOI: http://dx.doi.org/10.5217/ir.2016.14.2.152
      
10 Follow-up Testing of Interferon-Gamma Release Assays Are Useful in Ankylosing Spondylitis Patients Receiving Anti-Tumor Necrosis Factor Alpha for Latent Tuberculosis Infection
Chang-Nam Son, Jae-Bum Jun, Jong-Heon Kim, Il-Hoon Sung, Dae-Hyun Yoo, Tae-Hwan Kim
J Korean Med Sci.2014;29(8):1090-1093.   Published online 2014 July 30     DOI: http://dx.doi.org/10.3346/jkms.2014.29.8.1090
      
11 Dermatological Side Effects of antitumor Necrosis Factor Alpha Therapy
Seong Hun Moon, Joo Yeon Ko
J Rheum Dis.2014;21(1):9-19.   Published online 2014 March 3     DOI: http://dx.doi.org/10.4078/jrd.2014.21.1.9
   

 1 of 1